Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
about
Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives.CRTH2 antagonists in asthma: current perspectives.ML-7 attenuates airway inflammation and remodeling via inhibiting the secretion of Th2 cytokines in mice model of asthma.Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonists in asthma: a systematic review and meta-analysis protocol.
P2860
Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
@en
type
label
Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
@en
prefLabel
Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
@en
P2860
P1476
Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
@en
P2093
Garry M Walsh
P2860
P304
P356
10.1080/1744666X.2016.1216316
P577
2016-07-26T00:00:00Z